Diprogent

Country of origin: Switzerland, Schering-Plough United States of America, Schering-Plough Belgium

Pharm-Group: Combined products containing glucocorticosteroids

Manufacturers: Schering-Plough (Switzerland), Schering-Plough (United States of America), Schering-Plough (Belgium)

International name: Gentamicin + Betamethasone

Synonyms: Akriderm GENTA, Belogent, Betagenot, Betagentam, Garazon, Kuterid G, Celestoderm with gentamicin, Celestoderm B with garamicin, Celestoderm-B with garamicin

Dosage forms: ointment, cream

Composition: Active ingredients - gentamicin and betamethasone.

Indications for use: Infected skin lesions: dermatoses (treatment and prevention), allergic and eczematous skin diseases (acute, subacute and chronic forms), acute non-allergic dermatitis (solar, X-ray, after insect bites); skin infection with ordinary psoriasis, exfoliative dermatitis, lichen planus.

Contraindications: Hypersensitivity, chicken pox, skin tuberculosis, vaccination, breastfeeding. Use during pregnancy and breastfeeding: Prescribed during pregnancy in exceptional cases.

Side effects: Burning, itching, irritation, dry skin, folliculitis, hypertrichosis, acne, hypopigmentation; when used under occlusive dressings - maceration, skin atrophy, stretch marks, prickly heat; with prolonged treatment and/or application to large surfaces - systemic side effects.

Interaction: No data available.

Overdose: No data.

Special instructions: Use with caution in children. If signs of sensitization or irritation appear, treatment should be discontinued. If superinfection develops, the drug is discontinued and adequate antibacterial therapy is prescribed.

Literature: Encyclopedia of Medicines, 2003.